Redhawk Wealth Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,271
Closed -$1.3M 346
2025
Q1
$1.3M Sell
4,271
-620
-13% -$209K 0.18% 105
2024
Q4
$1.62M Buy
4,891
+272
+6% +$92.2K 0.22% 91
2024
Q3
$1.54M Buy
4,619
+207
+5% +$78.6K 0.22% 97
2024
Q2
$1.82M Sell
4,412
-919
-17% -$364K 0.28% 78
2024
Q1
$2.15M Sell
5,331
-24
-0.4% -$8.44K 0.35% 63
2023
Q4
$1.64M Buy
5,355
+99
+2% +$26.7K 0.32% 72
2023
Q3
$1.27M Buy
5,256
+341
+7% +$87.2K 0.42% 56
2023
Q2
$1.18M Buy
4,915
+931
+23% +$193K 0.36% 62
2023
Q1
$749K Buy
+3,984
New +$824K 0.25% 92
2020
Q2
Sell
-3,497
Closed -$257K 186
2020
Q1
$257K Buy
+3,497
New +$304K 0.12% 122

Other funds holding MEDP

Redhawk Wealth Advisors's MEDP Position: Q2 2025 in Review

Redhawk Wealth Advisors sold out of Medpace (MEDP) in Q2 2025, closing a stake of 4,271 shares — an estimated $1.3M sold.

Redhawk Wealth Advisors first reported a position in MEDP in Q1 2020 and held it in 10 quarters. The position peaked at $2.15M in Q1 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • Redhawk Wealth Advisors reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 4,271 Medpace shares in Q2 2025, an estimated $1.3M.
  • Redhawk Wealth Advisors first reported a position in Medpace in Q1 2020 and held it in 10 quarters.
  • Redhawk Wealth Advisors's Medpace position peaked at $2.15M in Q1 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2025, filed 10 Jul 2025.